Synergistic HIV latency reversal from an in vitro screen of epigenetic and kinase inhibitors

Synergistic HIV latency reversal from an in vitro screen of epigenetic and kinase inhibitors

Bibliographic Details
Main Authors:	D. Irlbeck, Y. Zhao, A. Axtman, B. Zuercher, L. Ingerman-James
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020306774

Similar Items

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019-12-01)

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
by: Donya Naz Divsalar, et al.
Published: (2020-06-01)

SMAC mimetics reverse HIV latency by selective activation of the non-canonical NF-κB pathway
by: G.C. Sampey, et al.
Published: (2017-12-01)

Epigenetic regulation of HIV-1 latency by cytosine methylation.
by: Steven E Kauder, et al.
Published: (2009-06-01)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016-07-01)

Combinatorial Use of Both Epigenetic and Non-Epigenetic Mechanisms to Efficiently Reactivate HIV Latency
by: Joseph Hokello, et al.
Published: (2021-04-01)

The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate.
by: Michael Bobardt, et al.
Published: (2019-01-01)

Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
by: Mateusz Stoszko, et al.
Published: (2016-01-01)

Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?
by: Thanarat Salahong, et al.
Published: (2021-05-01)

Validation of an unbiased screen method for the identification of secondary fungal metabolites reversing HIV-1 latency
by: M. Stoszko, et al.
Published: (2017-12-01)

Identification of celastrol as a novel HIV-1 latency reversal agent by an image-based screen.
by: Hongbing Liu, et al.
Published: (2021-01-01)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017-12-01)

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
by: Ole S Søgaard, et al.
Published: (2015-09-01)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016-07-01)

38 Small molecule inhibitors of BAF; a new family of compounds in HIV-1 latency reversal
by: E. De Crignis, et al.
Published: (2016-07-01)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
by: Renée M Van der Sluis, et al.
Published: (2020-02-01)

Targeted screens identify new chromatin regulators of HIV latency
by: A.-M. Turner, et al.
Published: (2017-12-01)

Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome
by: Joseph Hokello, et al.
Published: (2020-08-01)

RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency
by: Catalina Méndez, et al.
Published: (2018-10-01)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019-12-01)

Epigenetic Control of Cytomegalovirus Latency and Reactivation
by: Mary Hummel, et al.
Published: (2013-05-01)

SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo
by: R.M. Dunham, et al.
Published: (2017-12-01)

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
by: Sushant Khanal, et al.
Published: (2021-02-01)

SCREENING FOR EPIGENETIC INHIBITORS OF OSTEOSARCOMA METASTASIS
by: Bayles, Ian Matthew
Published: (2020)

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
by: Christiane Margue, et al.
Published: (2019-02-01)

Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency
by: Daniela A. Covino, et al.
Published: (2021-06-01)

Leveraging Novel Integrated Single-Cell Analyses to Define HIV-1 Latency Reversal
by: Suhui Zhao, et al.
Published: (2021-06-01)

Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro
by: Shin-ichiro Hattori, et al.
Published: (2018-09-01)

Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins
by: Sheraz Khan, et al.
Published: (2018-02-01)

Integration site-independent enhancement of latency reversal by HIV-1 Nef
by: X.T. Kuang, et al.
Published: (2017-12-01)

Cleavage and polyadenylation specific factor 6 is required for HIV latency reversal
by: Y. Zheng, et al.
Published: (2019-12-01)

NMR Metabonomics in an in vitro Model of HIV-1 latency
by: Nonodi, Thato Pearl
Published: (2017)

The SMAC mimetic AZD5582 reverses HIV latency as a single agent in resting primary CD4+ T cells
by: G. Sampey, et al.
Published: (2019-07-01)

Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
by: Ugur Eskiocak, et al.
Published: (2016-08-01)

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1
by: María Rosa López-Huertas, et al.
Published: (2017-05-01)

A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association
by: Huachao Huang, et al.
Published: (2017-06-01)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015-12-01)

4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.
by: J. Jacobson, et al.
Published: (2017-07-01)

Novel use of alprazolam as a potential HIV-1 latency reversing agent
by: W. Elbezanti, et al.
Published: (2017-12-01)

Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells In vitro
by: Eric Freund, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_jred5ifjapoalsaf4tq0o8dtdb